Surgery Partners

The site-neutrality movement has rapidly become one of the most talked-about issues in health care. But what does it mean for ambulatory surgery center operators?  At its core, site neutrality is about leveling the playing field between different outpatient settings by eliminating the extra facility fees that hospital outpatient departments (HOPDs) often receive, Rachel Carey, counsel at Whiteford, Taylor & Preston LLP, told Ambulatory Surgery Center News. “It's a movement to … [Read more...]

For years, ambulatory surgery centers (ASCs) have operated at a reimbursement disadvantage compared to hospital outpatient departments (HOPDs) and other – often costlier – health care settings. Yet a growing push for site-neutral payments could soon level the playing field, potentially reshaping the financial landscape for ASCs, hospitals and payers alike. And Brentwood, Tennessee-based Surgery Partners (Nasdaq: SGRY) is embracing the movement wholeheartedly, according to CEO Eric … [Read more...]

Following a go-private proposal from Bain Capital Private Equity and other sales-process rumors that began last year, ambulatory surgery center (ASC) industry insiders have been following Surgery Partners Inc. (Nasdaq: SGRY) very closely. Amid the noise, the Surgery Partners leadership team is sticking to its playbook: organic growth, margin improvement and strategic M&A. It’s a strategy that drove the Brentwood, Tennessee-based company to cross $3 billion in revenue for the first time in … [Read more...]

Surgery Partners has confirmed it received a non-binding acquisition proposal from Bain Capital Private Equity. The proposal was delivered to ambulatory surgery center (ASC) giant Surgery Partners on Jan. 27. In it, Bain Capital proposed to buy all of the outstanding shares of Surgery Partners it doesn’t already own for a cash consideration of $25.75 per share. Bain Capital and its affiliates own about 39% of Surgery Partners’ common stock. Moving forward, a special committee of … [Read more...]

Surgery Partners (Nasdaq: SGRY) has been exploring a possible sale since at least July, according to multiple news reports. Now, the surgical services giant appears to have a proposal on the table. On Monday evening, Bain Capital Private Equity reached out to the Surgery Partners board with a non-binding proposal to acquire all of the company’s stock it does not already own for $25.75 per share. The proposal was documented via public financial filings with the U.S. Securities and Exchange … [Read more...]

Last year was a pivotal year for the ambulatory surgery center (ASC) industry, marked by transformative trends, groundbreaking innovations and high-stakes decisions that reshaped the landscape. It was also an exciting year for us at Ambulatory Surgery Center News, as we launched in the summer of 2024 with a mission to deliver in-depth reporting and actionable insights tailored to ASC operators, investors, payers, clinicians and other stakeholders. Since our debut, we've brought you stories … [Read more...]

GLP-1s and Medicare Advantage (MA) are two potential headwinds for ambulatory surgery centers (ASCs), with each undoubtedly playing a larger role in 2025. Partly because of this increasingly prominent standing, the U.S. Centers for Medicare & Medicaid Service (CMS) proposed new policies related to both GLP-1s, or glucagon-like peptide-1s, and MA on Nov. 26. “This proposed rule includes more policies to remove unnecessary barriers to care stemming from the use of inappropriate prior … [Read more...]

You can often take the pulse of any industry by analyzing the words of its leaders. And while there were plenty of interesting quotes from ambulatory surgery center (ASC) leaders in our reporting this year, a few stood out for their thoughtfulness, candor and relevance. From pricing transparency and strategic partnerships, to navigating compliance and the growing shift towards high-acuity procedures, these quotes capture the essence of the challenges and opportunities facing ASCs … [Read more...]

Executives with Surgery Partners (Nasdaq: SGRY) conveyed a bullish message on the potential for growth and remained quiet on the rumors of a potential company sale during Tuesday’s Q3 2024 earnings call. High-acuity procedures and strategic acquisitions are, and will continue to be, core drivers of growth, the leaders said. “Transition into the ASC setting – that shift in site of care – is in the early innings, and we are well-positioned, with our recruiting team and our portfolio of … [Read more...]

The Federal Reserve’s recent decision to cut interest rates by half a percentage point marks a shift in monetary policy, signaling that inflation is cooling and that the central bank may now be focused on keeping the labor market stable.  In turn, that could mean there’s more ambulatory surgery center (ASC) transaction activity on the horizon. “We’re trying to achieve a situation where we restore price stability without the kind of painful increase in unemployment that has come sometimes … [Read more...]